MediWound (MDWD) EBIT Margin (2014 - 2025)
MediWound (MDWD) recorded quarterly EBIT Margin of 417.78% in Q4 2025, down 247.61% quarter-over-quarter from 120.19% in Q3 2025, and down 31331.0% on a YoY basis from N/an in Q4 2024.
MediWound (MDWD) EBIT Margin (2014 - 2025) Analysis & Trends
MediWound's EBIT Margin history runs 12 years deep, the most recent figure standing at 417.78% for Q4 2025.
- In Q4 2025, EBIT Margin fell 31331.0% year-over-year to 417.78%; the TTM figure through Dec 2025 stood at 167.05% (down 6310.0% YoY), while the FY2025 annual figure was 148.98%, down 5305.0% from the prior year.
- EBIT Margin was 417.78% for Q4 2025 at MediWound, down from 120.19% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 18.27% in Q4 2022 to a low of 417.78% in Q4 2025.
- Historically, EBIT Margin has averaged 108.41% across 5 years, with a median of 100.12% in 2021.
- The sharpest annual moves came in 2022 and 2025: EBIT Margin surged 8244 bps in 2022, then tumbled 31331 bps in 2025.
- A 5-year view of EBIT Margin shows it stood at 64.17% in 2021, then jumped by 128 bps to 18.27% in 2022, then slumped by 499 bps to 72.95% in 2023, then plunged by 43 bps to 104.47% in 2024, then tumbled by 300 bps to 417.78% in 2025.
- The last three EBIT Margin figures came in at 417.78% (Q4 2025), 120.19% (Q3 2025), and 147.55% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -6.43% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 | -417.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -417.78% |
| Sep 30, 2025 | -120.19% |
| Jun 30, 2025 | -147.55% |
| Mar 31, 2025 | -132.11% |
| Dec 31, 2024 | -104.47% |
| Sep 30, 2024 | -116.67% |
| Jun 30, 2024 | -127.97% |
| Mar 31, 2024 | -75.22% |
| Dec 31, 2023 | -72.95% |
| Sep 30, 2023 | -63.34% |
| Jun 30, 2023 | -113.38% |
| Mar 31, 2023 | -114.87% |
| Dec 31, 2022 | 18.27% |
| Sep 30, 2022 | -60.49% |
| Jun 30, 2022 | -132.30% |
| Mar 31, 2022 | -74.52% |
| Dec 31, 2021 | -64.17% |
| Sep 30, 2021 | -87.47% |
| Jun 30, 2021 | -95.77% |
| Mar 31, 2021 | -65.34% |